In some diseases that affect pulmonary function, such as cystic fibrosis and chronic obstructive pulmonary disease (COPD), carbon dioxide levels in the blood accumulate owing to the inability of the body to properly regulate ventilation. The resulting condition is called hypercapnia acidosis, which can disrupt cardiac and neurological function, and impair the immune response. Helenius et al. found that when Drosophila were exposed to high levels of carbon dioxide, they changed their gene profiles and suppressed their production of antimicrobial peptides. Hypercapnia in flies impaired their ability to survive infection with a variety of bacterial strains by inhibiting their resistance to infection. In mammals, hypercapnia can suppress immune function through its inhibition of the NFκB pathway. In hypercapnic flies, the downregulated immune peptides are regulated by Relish, which is a conserved member of this pathway. Flies exposed to high carbon dioxide levels also exhibit developmental and reproductive changes. The genetic tractability of Drosophila, and the molecular conservation of its innate immune response with mammals, make this a useful model to understand some of the ways that hypercapnia acidosis impairs immunity and possibly contributes to the poor outcomes of patients with obstructive lung disease.
Infectious disease: CO2 levels contribute to infection Open Access
Infectious disease: CO2 levels contribute to infection. Dis Model Mech 14 January 2010; 3 (1-2): 2. doi:
Download citation file:
Advertisement
Cited by
Interviews with Biologists @ 100 conference speakers

Explore our interviews with keynote speakers from the Biologists @ 100 conference, hosted to celebrate our publisher’s 100th anniversary, where we discuss climate change and biodiversity with Hans-Otto Pörtner and Jane Francis, health and disease with Charles Swanton and Sadaf Farooqi, and emerging technologies with Manu Prakash and Jennifer Lippincott-Schwartz.
A new perspective on disease research
DMM publishes perspectives – peer-reviewed articles that provide expert analysis of a topic important to the disease research community. Read our collection from authors presenting new or potentially controversial ideas or hypotheses, to help address future challenges and forge new directions.
Read & Publish Open Access publishing: what authors say

We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Fast & Fair peer review

Our sister journal Biology Open has recently launched the next phase of their Fast & Fair peer review initiative: offering high-quality peer review within 7 working days. To learn more about BiO’s progress and future plans, read the Editorial by Daniel Gorelick, or visit the Fast & Fair peer review page.
History of our journals

As our publisher, The Company of Biologists, turns 100 years old, read about DMM’s history and explore the journey of each of our sister journals: Development, Journal of Cell Science, Journal of Experimental Biology and Biology Open.
Other journals from
The Company of Biologists